CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $235.7 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of $3.16 per share.
The biopharmaceutical company posted revenue of $100.1 million in the period.
For the year, the company reported that its loss widened to $715.1 million, or $9.71 per share. Revenue was reported as $380.8 million.
Sarepta Therapeutics shares have declined 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $113.63, a fall of 19% in the last 12 months.